Next Science Limited (ASX: NXS) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Next Science Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Next Science Limited (ASX: NXS)
    Latest News

    a woman
    Share Market News

    Is Paradigm the real deal blockbuster biotech?

    Paradigm is a speculative biotech business exciting investors with news over its Zilosul drug's potential to treat osteoarthritis.

    Read more »

    a woman
    Share Market News

    Why the Polynovo share price is now up 24x in 5 years

    The Polynovo Ltd (ASX: PNV) share price is up 7% to $2.43 this lunchtime despite the biotech not releasing any…

    Read more »

    a woman
    Share Market News

    Paradigm reports "ground-breaking" osteoarthritis discovery: Is it the real deal?

    Paradigm Biopharmaceuticals (ASX:PAR) is looking to partner with big pharma.

    Read more »

    a woman
    Share Market News

    Is Paradigm Biopharmaceuticals the share market's next huge winner?

    Paradigm: Buy the rumour, sell the news?

    Read more »

    a woman
    Share Market News

    Why the Bionomics share price is up 40% today

    Bionomics Ltd (ASX: BNO) looks very speculative.

    Read more »

    a woman
    Share Market News

    Paradigm share price tanks despite positive clinical trial update

    Paradigm Biopharmaceuticals Ltd (ASX: PAR) is a speccy biotech that could sink or soar.

    Read more »

    a woman
    Share Market News

    Why the Mesoblast share price is going nuts today

    Mesoblast limited (ASX: MSB) has signed an important partnership with Grünenthal.

    Read more »

    a woman
    Share Market News

    Why Telix Pharmaceuticals shares are up 80% over the past year

    Telix Pharmaceuticals is an oncology researcher with a renal cancer treatment at the Phase III stage.

    Read more »

    a woman
    Share Market News

    Biotech speccy Paradigm is being tipped for the big time

    Paradigm (ASX: PAR) has $78 million cash on hand and a goal to commercialise osteoarthritis drugs.

    Read more »

    a woman
    Share Market News

    Why the Next Science share price has more than tripled in 2019

    Next Science (ASX: NXS) and Paradigm (ASX: PAR) are two widely fancied speccy biotechs.

    Read more »

    a woman
    Share Gainers

    These recent IPOs have smashed the ASX 200 in 2019

    If you bought the shares of Next Science Ltd (ASX:NXS) and two others at their IPO you'd have made a handsome return on…

    Read more »

    a woman
    Share Market News

    How this fund manager smashed the market over the last 12 months

    Afterpay Touch Group (ASX:APT), Next Science Limited (ASX:NXS), Zip Co Limited (ASX: Z1P), and two others have helped this fund…

    Read more »

    NXS ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    Profile

    since

    Note